Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Westman, Eric ^a   Cavallin, Lena ^a,b   Muehlboeck, J Sebastian ^a   Zhang, Yi ^a   Mecocci, Patrizia ^c   Vellas, Bruno ^d   Tsolaki, Magda ^e   Kłoszewska, Iwona ^f   Soininen, Hilkka ^g   Spenger, Christian ^a   Lovestone, Simon ^h,i   Simmons, Andrew ^h,i   Wahlund, Lars Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ King s College London   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HIPPOCAMPUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RATING SCALE; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; VISUAL ASSESSMENT RATING SCALE; CLASSIFICATION; COGNITIVE DEFECT; COHORT ANALYSIS; FOLLOW UP; METHODOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS; REPRODUCIBILITY; STATISTICAL MODEL;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEAST-SQUARES ANALYSIS; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 79960645134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022506     Document Type: Article

References (47)

1. Kantarci K, (2005) Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease. Expert Rev Neurother 5: 663-670.
2. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, et al. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. The Lancet Neurology 6: 734-746.
3. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269.
4. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM, (2008) Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage 41: 1220-1227.
5. Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, et al. (2008) Automatic classification of MR scans in Alzheimer's disease. Brain 131: 681-689.
6. Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, et al. (2011) Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage 54: 1178-1187.
7. Westman E, Wahlund L-O, Foy C, Poppe M, Cooper A, et al. (2010) Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J Alzheimers Dis 22: 171-181.
8. Kloppel S, Stonnington CM, Barnes J, Chen F, Chu C, et al. (2008) Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 131: 2969-2974.
9. Westman E, Simmons A, Muehlboeck S, Mecocci P, Vellas B, et al. (2011) AddNeuroMed and ADNI: Similar Patterns of Alzheimer's Atrophy and Automated MRI Classification Accuracy in Europe and North America. NeuroImage In press.
10. Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, et al. (2009) AddNeuroMed;The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease. Annals of the New York Academy of Sciences 1180: 36-46.
11. Lovestone S, Francis P, Strandgaard K, (2007) Biomarkers for disease modification trials-the innovative medicines initiative and AddNeuroMed. J Nutr Health Aging 11: 359-361.
12. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, et al. (1992) Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55: 967-972.
13. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al. (2011) The AddNeuroMed framework for multi-centre MRI assessment of longitudinal changes in Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry 26 (1): 75-82.
14. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al. (2009) MRI Measures of Alzheimer's Disease and the AddNeuroMed Study. Annals of the New York Academy of Sciences 1180: 47-55.
15. Rosen WG, Mohs RC, Davis KL, (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141: 1356-1364.
16. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, et al. (2008) The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27: 685-691.
17. Segonne F, Dale AM, Busa E, Glessner M, Salat D, et al. (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22: 1060-1075.
18. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, et al. (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341-355.
19. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, et al. (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23 (Suppl 1): S69-84.
20. Sled JG, Zijdenbos AP, Evans AC, (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17: 87-97.
21. Fischl B, Liu A, Dale AM, (2001) Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20: 70-80.
22. Segonne F, Pacheco J, Fischl B, (2007) Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 26: 518-529.
23. Dale AM, Fischl B, Sereno MI, (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9: 179-194.
24. Dale AM, Sereno MI, (1993) Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach. Journal of Cognitive Neuroscience 5: 162-176.
25. Fischl B, Dale AM, (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97: 11050-11055.
26. Fischl B, Sereno MI, Tootell RB, Dale AM, (1999) High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8: 272-284.
27. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, et al. (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31: 968-980.
28. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, et al. (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex 14: 11-22.
29. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund L-O, et al. (2011) Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging 32: 1198-1206.
30. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund L-O, et al. (2010) Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiology of Aging 31: 1375-1385.
31. Tunnard C, Whitehead D, Hurt C, Wahlund L-O, Mecocci P, et al. (2011) Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 26: 741-748.
32. Liu Y, Paajanen T, Westman E, Wahlund L-O, Simmons A, et al. (2010) Effect of APOE epsilon4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis 21: 947-966.
33. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund L-O, et al. (2010) APOE epsilon2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord 30: 229-237.
34. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67: 739-748.
35. Pantel J, O'Leary DS, Cretsinger K, Bockholt HJ, Keefe H, et al. (2000) A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus 10: 752-758.
36. Bylesjo M, Eriksson D, Kusano M, Moritz T, Trygg J, (2007) Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J 52: 1181-1191.
37. Johan Trygg SW, (2002) Orthogonal projections to latent structures (O-PLS). Journal of Chemometrics 16: 119-128.
38. Rantalainen M, Cloarec O, Beckonert O, Wilson ID, Jackson D, et al. (2006) Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteome Res 5: 2642-2655.
39. Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, et al. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80: 115-122.
40. Levine B, Kovacevic N, Nica EI, Cheung G, Gao F, et al. (2008) The Toronto traumatic brain injury study: Injury severity and quantified MRI. Neurology 70: 771-778.
41. McIntosh AR, Lobaugh NJ, (2004) Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage 23: S250-S263.
42. Oberg J, Spenger C, Wang FH, Andersson A, Westman E, et al. (2007) Age related changes in brain metabolites observed by (1)H MRS in APP/PS1 mice. Neurobiol Aging 29 (9): 1423-33.
43. Westman E, Spenger C, Oberg J, Reyer H, Pahnke J, et al. (2009) In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci 10: 33.
44. Westman E, Spenger C, Wahlund L-O, Lavebratt C, (2007) Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1mceph/mceph. Neurobiology of Disease 26: 221-228.
45. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wiksröm C, et al. (2006) Multi- and Megavariate Data Analysis (Part I-Basics and Principals and Applications) Umeå Umetrics AB.
46. Qizilbash N, Schneider L, Chui H, Tariot P, Brodaty H, et al.eds. (2002) Evindenced-based Dementia Pratice Oxford, UK Blackwell Publishing pp. 20-23.
47. Blennow K, de Leon MJ, Zetterberg H, (2006) Alzheimer's disease. The Lancet 368: 387-403.